End-of-day quote
Thailand S.E.
06:00:00 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
67.5
THB
|
0.00%
|
|
+1.89%
|
+20.54%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
12,750
|
11,775
|
13,725
|
14,700
|
18,000
|
18,975
|
Enterprise Value (EV)
1 |
9,538
|
7,181
|
9,080
|
9,885
|
13,003
|
13,037
|
P/E ratio
|
4.93
x
|
4.92
x
|
13.2
x
|
3.43
x
|
4.45
x
|
4.13
x
|
Yield
|
2.59%
|
3.06%
|
1.75%
|
3.37%
|
2.33%
|
-
|
Capitalization / Revenue
|
1.49
x
|
1.57
x
|
2.67
x
|
1.42
x
|
1.4
x
|
1.33
x
|
EV / Revenue
|
1.11
x
|
0.96
x
|
1.77
x
|
0.96
x
|
1.01
x
|
0.91
x
|
EV / EBITDA
|
5
x
|
4.21
x
|
7.52
x
|
4.84
x
|
8.56
x
|
3.71
x
|
EV / FCF
|
10.9
x
|
5.36
x
|
30.3
x
|
81.3
x
|
30.5
x
|
6.68
x
|
FCF Yield
|
9.16%
|
18.7%
|
3.3%
|
1.23%
|
3.28%
|
15%
|
Price to Book
|
0.69
x
|
0.59
x
|
0.66
x
|
0.59
x
|
0.64
x
|
0.57
x
|
Nbr of stocks (in thousands)
|
300,000
|
300,000
|
300,000
|
300,000
|
300,000
|
300,000
|
Reference price
2 |
42.50
|
39.25
|
45.75
|
49.00
|
60.00
|
63.25
|
Announcement Date
|
5/27/19
|
5/29/20
|
5/25/21
|
5/27/22
|
5/29/23
|
5/30/24
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
8,555
|
7,499
|
5,139
|
10,337
|
12,893
|
14,264
|
EBITDA
1 |
1,909
|
1,706
|
1,208
|
2,041
|
1,518
|
3,515
|
EBIT
1 |
1,695
|
1,469
|
997.1
|
1,861
|
1,336
|
3,326
|
Operating Margin
|
19.81%
|
19.59%
|
19.4%
|
18%
|
10.36%
|
23.31%
|
Earnings before Tax (EBT)
1 |
3,034
|
2,849
|
1,211
|
4,859
|
4,563
|
5,398
|
Net income
1 |
2,585
|
2,394
|
1,036
|
4,287
|
4,049
|
4,593
|
Net margin
|
30.21%
|
31.93%
|
20.17%
|
41.47%
|
31.4%
|
32.2%
|
EPS
2 |
8.616
|
7.981
|
3.455
|
14.29
|
13.50
|
15.31
|
Free Cash Flow
1 |
874.1
|
1,340
|
299.6
|
121.6
|
426.3
|
1,951
|
FCF margin
|
10.22%
|
17.87%
|
5.83%
|
1.18%
|
3.31%
|
13.68%
|
FCF Conversion (EBITDA)
|
45.79%
|
78.56%
|
24.81%
|
5.96%
|
28.08%
|
55.5%
|
FCF Conversion (Net income)
|
33.82%
|
55.99%
|
28.91%
|
2.84%
|
10.53%
|
42.47%
|
Dividend per Share
2 |
1.100
|
1.200
|
0.8000
|
1.650
|
1.400
|
-
|
Announcement Date
|
5/27/19
|
5/29/20
|
5/25/21
|
5/27/22
|
5/29/23
|
5/30/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3,212
|
4,594
|
4,645
|
4,815
|
4,997
|
5,938
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
874
|
1,340
|
300
|
122
|
426
|
1,951
|
ROE (net income / shareholders' equity)
|
14.9%
|
12.5%
|
5.07%
|
18.7%
|
15.2%
|
15%
|
ROA (Net income/ Total Assets)
|
5.59%
|
4.44%
|
2.84%
|
4.63%
|
2.84%
|
6.11%
|
Assets
1 |
46,252
|
53,918
|
36,498
|
92,639
|
142,590
|
75,191
|
Book Value Per Share
2 |
61.20
|
67.00
|
69.40
|
83.40
|
93.80
|
110.0
|
Cash Flow per Share
2 |
5.740
|
15.30
|
15.50
|
16.00
|
16.70
|
19.80
|
Capex
1 |
296
|
195
|
27.6
|
70.9
|
191
|
1,060
|
Capex / Sales
|
3.46%
|
2.59%
|
0.54%
|
0.69%
|
1.48%
|
7.43%
|
Announcement Date
|
5/27/19
|
5/29/20
|
5/25/21
|
5/27/22
|
5/29/23
|
5/30/24
|
|
1st Jan change
|
Capi.
|
---|
| +20.54% | 553M | | +20.59% | 67.26B | | -0.33% | 48.54B | | +24.23% | 44.21B | | +29.48% | 28.1B | | +7.49% | 19.23B | | +10.75% | 16.84B | | -5.41% | 15.86B | | -23.26% | 14.76B | | -17.88% | 13.9B |
Other Specialty Chemicals
|